Atossa Genetics Stock Cash Flow From Operations
| ATOS Stock | USD 0.78 0.01 1.09% |
Fundamental analysis of Atossa Genetics allows traders to better anticipate movements in Atossa Genetics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Atossa | Cash Flow From Operations | Build AI portfolio with Atossa Stock |
Atossa Genetics Company Cash Flow From Operations Analysis
Atossa Genetics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Atossa Genetics Cash Flow From Operations | (21.03 M) |
Most of Atossa Genetics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atossa Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Atossa Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for Atossa Genetics is extremely important. It helps to project a fair market value of Atossa Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Atossa Genetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Atossa Genetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Atossa Genetics' interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
Atossa Discontinued Operations
Discontinued Operations |
|
In accordance with the recently published financial statements, Atossa Genetics has (21.03 Million) in Cash Flow From Operations. This is 103.99% lower than that of the Health Care Equipment & Supplies sector and 133.63% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 102.17% higher than that of the company.
Atossa Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atossa Genetics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atossa Genetics could also be used in its relative valuation, which is a method of valuing Atossa Genetics by comparing valuation metrics of similar companies.Atossa Genetics is currently under evaluation in cash flow from operations category among its peers.
Atossa Genetics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Atossa Genetics from analyzing Atossa Genetics' financial statements. These drivers represent accounts that assess Atossa Genetics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Atossa Genetics' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 4.2M | 13.3M | 10.7M | 118.8M | 106.9M | 112.3M | |
| Enterprise Value | (6.1M) | 809.6K | (28.8M) | 47.7M | 54.9M | 57.6M |
Atossa Fundamentals
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 36.54 M | ||||
| Shares Outstanding | 129.17 M | ||||
| Shares Owned By Insiders | 0.07 % | ||||
| Shares Owned By Institutions | 26.78 % | ||||
| Number Of Shares Shorted | 4.09 M | ||||
| Price To Earning | (0.62) X | ||||
| Price To Book | 1.56 X | ||||
| EBITDA | (25.49 M) | ||||
| Net Income | (25.5 M) | ||||
| Cash And Equivalents | 125.54 M | ||||
| Cash Per Share | 0.99 X | ||||
| Total Debt | 4.97 M | ||||
| Current Ratio | 35.19 X | ||||
| Book Value Per Share | 0.51 X | ||||
| Cash Flow From Operations | (21.03 M) | ||||
| Short Ratio | 2.68 X | ||||
| Earnings Per Share | (0.20) X | ||||
| Target Price | 5.63 | ||||
| Number Of Employees | 15 | ||||
| Beta | 0.92 | ||||
| Market Capitalization | 101.66 M | ||||
| Total Asset | 76.44 M | ||||
| Retained Earnings | (211.79 M) | ||||
| Working Capital | 69.49 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 2.5 M | ||||
| Net Asset | 76.44 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.